BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weitz JE, Ritchlin CT. Mechanistic Insights from Animal Models of Psoriasis and Psoriatic Arthritis. Curr Rheumatol Rep 2013;15. [DOI: 10.1007/s11926-013-0377-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Siegel EL, Orbai A, Ritchlin CT. Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis. Current Opinion in Rheumatology 2015;27:111-7. [DOI: 10.1097/bor.0000000000000155] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
2 McGonagle D, Tan AL, Watad A, Helliwell P. Pathophysiology, assessment and treatment of psoriatic dactylitis. Nat Rev Rheumatol 2019;15:113-22. [PMID: 30610219 DOI: 10.1038/s41584-018-0147-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
3 Aggarwal D, Arumalla N, Jethwa H, Abraham S. The use of biomarkers as a tool for novel psoriatic disease drug discovery. Expert Opin Drug Discov 2018;13:875-87. [PMID: 30124339 DOI: 10.1080/17460441.2018.1508206] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 von Stebut E, Boehncke WH, Ghoreschi K, Gori T, Kaya Z, Thaci D, Schäffler A. IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications. Front Immunol 2019;10:3096. [PMID: 32010143 DOI: 10.3389/fimmu.2019.03096] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
5 Talotta R, Atzeni F, Sarzi-Puttini P, Masala IF. Psoriatic arthritis: From pathogenesis to pharmacologic management. Pharmacol Res 2019;148:104394. [PMID: 31505253 DOI: 10.1016/j.phrs.2019.104394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sheane BJ, Chandran V. Investigational drugs for treating psoriatic arthritis. Expert Opinion on Investigational Drugs 2014;23:1001-16. [DOI: 10.1517/13543784.2014.910194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Gao Y, Yao X, Zhai Y, Li L, Li H, Sun X, Yu P, Xue T, Li Y, Hu Y. Single cell transcriptional zonation of human psoriasis skin identifies an alternative immunoregulatory axis conducted by skin resident cells. Cell Death Dis 2021;12:450. [PMID: 33958582 DOI: 10.1038/s41419-021-03724-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Deng S, Cheng J, Zhao J, Yao F, Xu J. Natural Compounds for the Treatment of Psoriatic Arthritis: A Proposal Based on Multi-Targeted Osteoclastic Regulation and on a Preclinical Study. JMIR Res Protoc 2017;6:e132. [PMID: 28698171 DOI: 10.2196/resprot.7636] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
9 Ruano J, Suárez-Fariñas M, Shemer A, Oliva M, Guttman-Yassky E, Krueger JG. Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis. PLoS One 2016;11:e0148450. [PMID: 26849645 DOI: 10.1371/journal.pone.0148450] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
10 Niehues H, van den Bogaard EH. Past, present and future of in vitro 3D reconstructed inflammatory skin models to study psoriasis. Exp Dermatol 2018;27:512-9. [PMID: 29502346 DOI: 10.1111/exd.13525] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
11 Keren A, David M, Gilhar A. Novel nanosome delivery system combined with siRNA targeting the antimicrobial gene DFB4: a new approach for psoriasis management? Exp Dermatol 2014;23:464-5. [PMID: 24673207 DOI: 10.1111/exd.12397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]